Bloomage Historical Balance Sheet

688363 Stock

50.12 0.18 0.36%

Trend analysis of Bloomage Biotechnology Corp balance sheet accounts such as Net Tangible Assets of 3.4 B, Retained Earnings of 3 B or Other Assets of 337.4 M provides information on Bloomage Biotechnology's total assets, liabilities, and equity, which is the actual value of Bloomage Biotechnology to its prevalent stockholders. By breaking down trends over time using Bloomage Biotechnology balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Bloomage Biotechnology latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Bloomage Biotechnology is a good buy for the upcoming year.

Bloomage Biotechnology Inventory

1.37 Billion

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bloomage Biotechnology Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

About Bloomage Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Bloomage Biotechnology at a specified time, usually calculated after every quarter, six months, or one year. Bloomage Biotechnology Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Bloomage Biotechnology and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Bloomage currently owns. An asset can also be divided into two categories, current and non-current.

Bloomage Biotechnology Balance Sheet Chart

At present, Bloomage Biotechnology's Other Liabilities is projected to increase significantly based on the last few years of reporting. The current year's Retained Earnings is expected to grow to about 3 B, whereas Net Tangible Assets are forecasted to decline to about 3.4 B.

Other Liab Net Tangible Assets Retained Earnings Other Assets

Net Tangible Assets

The total assets of a company minus any intangible assets such as patents, copyrights, and goodwill; it represents the physical assets of a company.

Retained Earnings

The cumulative amount of net income that a company retains for reinvestment in its operations, rather than distributing it to shareholders as dividends.

Most accounts from Bloomage Biotechnology's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Bloomage Biotechnology current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bloomage Biotechnology Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

	2021	2024	2025 (projected)
Net Tangible Assets	5.2B	6.6B	3.4B
Other Liabilities	186.8M	214.8M	225.6M

Net Tangible Assets Other Liab

Bloomage Biotechnology balance sheet Correlations

	Other Liab	Net Tangible Assets	Retained Earnings	Other Assets	Other Stockholder Equity	Common Stock	Property Plant Equipment	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Net Receivables	Non Current Liabilities Total	Inventory	Other Current Assets	Total Liab	Deferred Long Term Liab	Short Long Term Debt	Total Current Assets	Short Term Debt	Intangible Assets	Good Will
Other Liab		0.89	0.92	0.9	-0.78	0.82	0.98	0.92	0.07	0.84	0.91	0.88	0.67	0.95	0.51	0.88	0.89	0.94	0.35	0.86	0.96	-0.27	0.85	-0.8	0.91	0.81
Net Tangible Assets	0.89		0.77	0.81	-0.74	0.9	0.87	0.99	0.11	0.87	1.0	0.77	0.81	0.83	0.47	0.98	0.88	0.85	0.38	0.88	0.92	-0.29	0.94	-0.78	0.99	0.68
Retained Earnings	0.92	0.77		0.87	-0.59	0.59	0.95	0.83	-0.24	0.81	0.81	0.96	0.45	0.98	0.55	0.83	0.79	0.97	0.06	0.81	0.9	0.03	0.65	-0.59	0.76	0.94
Other Assets	0.9	0.81	0.87		-0.44	0.63	0.93	0.86	0.04	0.83	0.84	0.83	0.58	0.9	0.61	0.82	0.83	0.9	0.41	0.84	0.87	-0.03	0.77	-0.55	0.82	0.76
Other Stockholder Equity	-0.78	-0.74	-0.59	-0.44		-0.85	-0.67	-0.7	-0.16	-0.54	-0.72	-0.56	-0.65	-0.62	-0.14	-0.68	-0.64	-0.63	-0.32	-0.56	-0.73	0.61	-0.74	0.89	-0.75	-0.5
Common Stock	0.82	0.9	0.59	0.63	-0.85		0.75	0.87	0.23	0.68	0.89	0.61	0.85	0.69	0.19	0.83	0.75	0.71	0.44	0.7	0.84	-0.57	0.9	-0.89	0.93	0.53
Property Plant Equipment	0.98	0.87	0.95	0.93	-0.67	0.75		0.92	0.01	0.9	0.9	0.92	0.65	0.98	0.6	0.89	0.91	0.98	0.22	0.9	0.97	-0.11	0.82	-0.69	0.88	0.85
Total Assets	0.92	0.99	0.83	0.86	-0.7	0.87	0.92		0.06	0.92	1.0	0.84	0.77	0.88	0.55	0.98	0.92	0.9	0.31	0.92	0.94	-0.2	0.92	-0.74	0.98	0.75
Other Current Liab	0.07	0.11	-0.24	0.04	-0.16	0.23	0.01	0.06		0.07	0.05	-0.36	0.34	-0.17	0.08	-0.03	0.26	-0.2	0.49	0.11	0.05	-0.47	0.27	-0.18	0.15	-0.5
Total Current Liabilities	0.84	0.87	0.81	0.83	-0.54	0.68	0.9	0.92	0.07		0.88	0.84	0.61	0.84	0.81	0.85	0.97	0.86	0.13	1.0	0.86	0.1	0.77	-0.53	0.83	0.72
Total Stockholder Equity	0.91	1.0	0.81	0.84	-0.72	0.89	0.9	1.0	0.05	0.88		0.82	0.79	0.87	0.47	0.98	0.88	0.89	0.35	0.88	0.94	-0.26	0.93	-0.77	0.99	0.74
Accounts Payable	0.88	0.77	0.96	0.83	-0.56	0.61	0.92	0.84	-0.36	0.84	0.82		0.48	0.97	0.59	0.83	0.78	0.98	-0.01	0.83	0.88	0.1	0.66	-0.57	0.76	0.98
Cash	0.67	0.81	0.45	0.58	-0.65	0.85	0.65	0.77	0.34	0.61	0.79	0.48		0.57	0.24	0.78	0.66	0.6	0.38	0.62	0.79	-0.47	0.93	-0.71	0.85	0.38
Non Current Assets Total	0.95	0.83	0.98	0.9	-0.62	0.69	0.98	0.88	-0.17	0.84	0.87	0.97	0.57		0.53	0.87	0.83	1.0	0.11	0.85	0.95	-0.04	0.74	-0.65	0.84	0.94
Non Currrent Assets Other	0.51	0.47	0.55	0.61	-0.14	0.19	0.6	0.55	0.08	0.81	0.47	0.59	0.24	0.53		0.46	0.75	0.55	0.0	0.8	0.49	0.46	0.41	-0.08	0.41	0.45
Net Receivables	0.88	0.98	0.83	0.82	-0.68	0.83	0.89	0.98	-0.03	0.85	0.98	0.83	0.78	0.87	0.46		0.84	0.89	0.27	0.85	0.93	-0.21	0.91	-0.73	0.96	0.77
Non Current Liabilities Total	0.89	0.88	0.79	0.83	-0.64	0.75	0.91	0.92	0.26	0.97	0.88	0.78	0.66	0.83	0.75	0.84		0.83	0.25	0.98	0.88	-0.11	0.82	-0.66	0.86	0.64
Inventory	0.94	0.85	0.97	0.9	-0.63	0.71	0.98	0.9	-0.2	0.86	0.89	0.98	0.6	1.0	0.55	0.89	0.83		0.12	0.86	0.95	-0.03	0.76	-0.66	0.85	0.94
Other Current Assets	0.35	0.38	0.06	0.41	-0.32	0.44	0.22	0.31	0.49	0.13	0.35	-0.01	0.38	0.11	0.0	0.27	0.25	0.12		0.15	0.22	-0.52	0.49	-0.38	0.43	-0.09
Total Liab	0.86	0.88	0.81	0.84	-0.56	0.7	0.9	0.92	0.11	1.0	0.88	0.83	0.62	0.85	0.8	0.85	0.98	0.86	0.15		0.87	0.05	0.79	-0.56	0.85	0.71
Deferred Long Term Liab	0.96	0.92	0.9	0.87	-0.73	0.84	0.97	0.94	0.05	0.86	0.94	0.88	0.79	0.95	0.49	0.93	0.88	0.95	0.22	0.87		-0.24	0.89	-0.78	0.94	0.82
Short Long Term Debt	-0.27	-0.29	0.03	-0.03	0.61	-0.57	-0.11	-0.2	-0.47	0.1	-0.26	0.1	-0.47	-0.04	0.46	-0.21	-0.11	-0.03	-0.52	0.05	-0.24		-0.43	0.74	-0.36	0.13
Total Current Assets	0.85	0.94	0.65	0.77	-0.74	0.9	0.82	0.92	0.27	0.77	0.93	0.66	0.93	0.74	0.41	0.91	0.82	0.76	0.49	0.79	0.89	-0.43		-0.8	0.96	0.55
Short Term Debt	-0.8	-0.78	-0.59	-0.55	0.89	-0.89	-0.69	-0.74	-0.18	-0.53	-0.77	-0.57	-0.71	-0.65	-0.08	-0.73	-0.66	-0.66	-0.38	-0.56	-0.78	0.74	-0.8		-0.81	-0.51
Intangible Assets	0.91	0.99	0.76	0.82	-0.75	0.93	0.88	0.98	0.15	0.83	0.99	0.76	0.85	0.84	0.41	0.96	0.86	0.85	0.43	0.85	0.94	-0.36	0.96	-0.81		0.67
Good Will	0.81	0.68	0.94	0.76	-0.5	0.53	0.85	0.75	-0.5	0.72	0.74	0.98	0.38	0.94	0.45	0.77	0.64	0.94	-0.09	0.71	0.82	0.13	0.55	-0.51	0.67

Click cells to compare fundamentals

Bloomage Biotechnology Account Relationship Matchups

Bloomage Biotechnology balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Other Liab	62.2M	56.4M	145.9M	186.8M	214.8M	225.6M
Net Tangible Assets	4.1B	4.5B	5.2B	5.8B	6.6B	3.4B
Retained Earnings	1.1B	1.7B	2.2B	2.5B	2.8B	3.0B
Other Assets	30.8M	69.5M	276.0M	279.4M	321.3M	337.4M
Other Stockholder Equity	409.0K	(1.2M)	(11.6K)	(23.9M)	(21.5M)	(20.4M)
Property Plant Equipment	492.6M	658.3M	1.3B	2.3B	2.7B	2.8B
Total Assets	5.7B	7.5B	8.7B	8.5B	9.7B	5.6B
Other Current Liab	173.1M	366.8M	7.8M	5.8M	6.6M	6.3M
Total Current Liabilities	552.9M	1.4B	1.6B	1.2B	1.4B	830.5M
Total Stockholder Equity	5.0B	5.7B	6.6B	6.9B	8.0B	4.6B
Accounts Payable	119.1M	243.5M	848.3M	700.8M	805.9M	846.2M
Cash	1.4B	1.8B	1.6B	1.2B	1.3B	1.4B
Non Current Assets Total	2.1B	3.5B	4.7B	5.3B	6.1B	6.5B
Non Currrent Assets Other	180.6M	445.5M	558.6M	263.6M	303.1M	266.6M
Net Receivables	372.4M	396.6M	448.4M	447.4M	514.5M	391.6M
Non Current Liabilities Total	145.9M	400.8M	354.7M	265.8M	305.7M	191.1M
Inventory	476.8M	709.1M	1.2B	1.1B	1.3B	1.4B
Other Current Assets	650.1M	190.4M	43.2M	40.1M	46.1M	43.8M
Total Liab	698.8M	1.8B	2.0B	1.5B	1.7B	1.0B
Deferred Long Term Liab	6.2M	18.9M	15.6M	31.8M	36.6M	38.5M
Total Current Assets	3.7B	4.0B	4.0B	3.1B	3.6B	3.0B
Intangible Assets	426.7M	467.3M	475.1M	497.0M	571.5M	353.9M
Good Will	74.6M	67.2M	247.2M	251.3M	289.0M	303.4M
Net Invested Capital	5.0B	5.9B	7.0B	7.1B	8.2B	5.2B
Net Working Capital	3.1B	2.6B	2.4B	1.9B	2.2B	2.4B
Property Plant And Equipment Net	1.2B	2.2B	2.8B	3.6B	4.2B	2.3B
Property Plant And Equipment Gross	1.6B	2.7B	2.8B	4.3B	5.0B	2.7B

Currently Active Assets on Macroaxis

BTC	Bitcoin
TRX	TRON
BNB	Binance Coin
ADA	Cardano
XRP	XRP

Other Information on Investing in Bloomage Stock

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Bloomage Historical Balance Sheet

Bloomage Biotechnology Inventory

1.37 Billion

About Bloomage Balance Sheet Analysis

Bloomage Biotechnology Balance Sheet Chart

Net Tangible Assets

Retained Earnings

Bloomage Biotechnology balance sheet Correlations

Bloomage Biotechnology Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Bloomage Biotechnology balance sheet Accounts

Currently Active Assets on Macroaxis

Other Information on Investing in Bloomage Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Net Tangible Assets
Total Stockholder Equity	+ 1.0	Total Assets
Total Liab	+ 1.0	Total Current Liabilities
Inventory	+ 1.0	Non Current Assets Total
Total Assets	+ 0.99	Net Tangible Assets
Intangible Assets	+ 0.99	Net Tangible Assets

Short Term Debt	- 0.89	Common Stock
Common Stock	- 0.85	Other Stockholder Equity
Intangible Assets	- 0.81	Short Term Debt
Short Term Debt	- 0.8	Total Current Assets
Short Term Debt	- 0.8	Other Liab
Short Term Debt	- 0.78	Deferred Long Term Liab